Professor Alberto Bernabe -
The John Marshall Law School
Friday, October 22, 2010
Dept of Justice to investigate Glaxo over issues with Avandia
Amid ongoing accusations that the pharmaceutical giant GlaxoSmithKline knew their diabetes drug Avandia increased the risk of heart attacks and tried to suppress that information, the Department of Justice (DOJ) has subpoenaed the drug maker to gain access to clinical data and marketing information. For more on this story go here.